At the forefront of innovation, compounding pharmacies are reshaping healthcare by providing tailored, patient-centric solutions. With a $6B market poised for 6.1% annual growth, the sector addresses critical gaps in medication shortages, rising drug costs, and the demand for personalized medicine.
What you'll learn:
- The Market potential with room for consolidation and scaling
- Growth drivers for the industry
- Private equity opportunities for investing
Whether you're an investor, a healthcare provider, or a patient, compounding pharmacies offer a unique opportunity to create impactful change in the pharmaceutical landscape.
Download the Report
The U.S. Pharma Premium: Who’s Really Paying the Price?
June 30, 2025
For decades, the United States has shouldered a disproportionate share of global pharmaceutical costs, accounting for 70% of global biopharma profits and over 80% of new drug launches. While this has helped drive significant medical innovation and supported the majority of global drug launches, it has also resulted in higher out-of-pocket costs for American patients.
When Security Creates Scarcity: DSCSA’s Unintended Consequence
June 2, 2025
In a recent article, A&M Life Sciences experts discuss The Drug Supply Chain Security Act and how well-intentioned regulations may be straining the very system they’re meant to safeguard.
Medtech CDMOs in 2025: Perspectives on Activity in the Medtech CDMO Market
May 19, 2025
Driving the future of medical innovation, Medtech CDMOs are leveraging strategic M&A and advanced technologies to scale growth. Amid regulatory complexity, key players are accelerating development and meeting rising demand for specialized manufacturing.
Discover the Future of Connected Health
May 2, 2025
Dive into "The Seven Truths of Connected Health," our latest Life Sciences report that explores how connected health changes patient behavior at key decision points.
